Sign inJoin waitlistJoin the waitlist

Shira N. Dinner

Associate Professor · Feinberg School of Medicine

Credentials: · · · ·

History

Feinberg School of Medicine
Present

Stanford Health Care-Sponsored Stanford University
Until 2013
University of Chicago
Until 2010
University of Chicago Pritzker School of Medicine
2007

Research

Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 257 citations
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
New England Journal of Medicine · 2024 · 235 citations
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Leukemia · 2018 · 209 citations

Michaela Liedtke
17 papers
Mark Litzow
16 papers
Madelyn Burkart
11 papers · 11 as a resident
Ehab Atallah
10 papers
Talha Badar
9 papers · 2 as a fellow
RS
Rory Shallis
8 papers
Ryan Mattison
8 papers
Anand Patel
7 papers · 3 as a fellow
Anjali Advani
7 papers
JY
Jay Yang
7 papers
Martha Wadleigh
7 papers
Selina Luger
7 papers

Clinical trials

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)
Principal investigator · Terminated · Phase 1
Northwestern University
2023–2024
Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 1
Northwestern University
2020–2022
Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Principal investigator · Terminated · Phase 1
Northwestern University
2017–2018
Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Principal investigator · Withdrawn · Phase 1
Northwestern University
2016